A Trial Investigating Lu AF28996 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

May 19, 2024

Study Completion Date

May 19, 2024

Conditions

Healthy Participants

Interventions

DRUG

Lu AF28996

Capsule

DRUG

Acetylsalicylic Acid

Tablet

DRUG

Mefenamic Acid

Tablet

DRUG

Amoxicillin/clavulanic acid

Tablet

Trial Locations (1)

Covance Dallas CRU, Dallas

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY

NCT06277609 - A Trial Investigating Lu AF28996 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter